In addition, ovarian cancer patient's tumour fluid expresses a higher concentration of cell-free urokinase plasminogen activator receptor (uPAR) (Pedersen et al, 1993) and high levels of cell-associated uPA correlate with advance stage disease (Tecimer et al, 2000). Here, PLAU is linked to ovarian carcinoma.